SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
SLNO (MC $24 M) Rare Disease in P3 a Potential Blockbuster
An SI Board Since August 2017
Posts SubjectMarks Bans Symbol
6 1 0 SLNO
Emcee:  BioHero Type:  Moderated
Min  Hr  Day  Wk  Mon  Yr  3 Yr  Log
SLNO 3.3500.0%Jan 28 12:00 AM EST
Top Headlines - Soleno Therapeutics, Inc.
17 Diagnostics & Research Stocks Moving In Tuesday's Session January 21
Soleno (SLNO) Ends Enrollment in Prader-Willi Syndrome Study January 7
Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Pr January 6
Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Pr January 6
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):